financetom
Business
financetom
/
Business
/
Market Chatter: GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link
May 23, 2024 11:15 AM

01:59 PM EDT, 05/23/2024 (MT Newswires) -- GSK (GSK) and Boehringer Ingelheim has won a lawsuit after a jury in Cook County, Illinois circuit court rejected claims that Zantac caused a woman's colon cancer, Reuters reported Thursday.

The jury decided plaintiff Angela Valadez failed to establish a direct link between her Zantac use and the disease, according to the report.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 45.06, Change: -0.73, Percent Change: -1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved